Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Wayne_Pisano
|
| gptkbp:focusesOn |
vaccine development
|
| gptkbp:foundedIn |
2002
|
| gptkbp:fundedBy |
gptkb:Biomedical_Advanced_Research_and_Development_Authority
gptkb:U.S._Department_of_Health_and_Human_Services |
| gptkbp:hasFormerCEO |
gptkb:Alan_Shaw
|
| gptkbp:headquartersLocation |
gptkb:Cranbury,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
VaxInnate
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:specializesIn |
influenza vaccines
recombinant vaccines |
| gptkbp:technology |
bacterial flagellin fusion proteins
|
| gptkbp:website |
http://www.vaxinnate.com
|
| gptkbp:bfsParent |
gptkb:Canaan_Partners
|
| gptkbp:bfsLayer |
6
|